Alphagan P
G*
|
brimonidine 0.1/0.15/0.2*% |
tid |
5/10/15mL |
>2 years |
B |
α-2 agonist
↓ aqueous production, ↑ outflow |
Azopt
G
|
brinzolamide 1% |
tid |
5/10/15mL |
Not Established |
C |
carbonic anhydrase inhibitor
↓ aqueous production |
Combigan
G
|
brimonidine 0.2%/timolol 0.5% |
bid |
5/10/15mL |
>2 years |
C |
α-2 agonist/β blocker
↓ aqueous production, ↑
outflow
|
Cosopt
G
|
dorzolamide 2%/timolol 0.5% |
bid |
5/10mL |
>2 years |
C |
carbonic anhydrase inhibitor/β blocker
↓ aqueous production
|
Diamox
PO G
|
acetazolamide |
500mg po bid |
125/250mg,
500mg ("Sequels") |
>12 years |
C |
carbonic anhydrase inhibitor
↓ aqueous production |
Isopto Carpine
G
|
pilocarpine 1/2/4% |
qd-qid |
15mL |
>2 years |
C |
cholinergic agonist
↑ outflow |
Lumigan
G*
|
bimatoprost 0.01/0.03*% |
qhs |
2.5/5/7.5mL |
>16 years |
C |
prostaglandin analogue
↑ outflow |
| Rhopressa
|
netarsudil 0.02% |
qhs |
2.5mL |
Not Established |
NA |
Rho kinase inhibitor
↑ outflow |
| Rocklatan
|
netarsudil 0.02%/latanoprost 0.005% |
qhs |
2.5mL |
Not Established |
NA |
Rho kinase inhibitor/prostagladin analogue
↑ outflow |
| Simbrinza
|
brimonidine 0.2%/brinzolamide 1% |
tid |
8mL |
>2 years |
C |
α-2 agonist/carbonic anhydrase inhibitor
↓ aqueous
production, ↑ outflow |
Timoptic
G
|
timolol maleate 0.25/0.5% |
bid |
5/10/15mL |
>2 years |
C |
β blocker
↓ aqueous production |
Travatan Z
G
|
travoprost 0.004% |
qhs |
2.5/5mL |
>16 years |
C |
prostagladin analogue
↑ outflow |
Trusopt
G
|
dorzolamide 2% |
bid-tid |
5/10mL |
>2 years |
C |
carbonic anhydrase inhibitor
↓ aqueous production |
| Vyzulta
|
latanoprostene bunod 0.024% |
qhs |
5mL |
>16 years |
NA |
prostagladin analogue
↑ outflow |
Xalatan
G
|
latanoprost 0.005% |
qhs |
2.5mL |
Not Established |
C |
prostagladin analogue
↑ outflow |
| Xelpros
|
latanoprost 0.005% (BAK free) |
qhs |
2.5mL |
Not Established |
C |
prostagladin analogue
↑ outflow |
| Zioptan
|
tafluprost 0.0015% |
qhs |
30/90 pack |
Not Recommended |
C |
prostagladin analogue
↑ outflow |